treatment with TNFi alone over continuing both medications (PICO 11). In adults with stable AS receiving treatment with TNFi and a conventional synthetic antirheumatic drug, we conditionally recommend continuing treatment with TNFi alone over continuing both medications ( No new studies have directly compared outcomes between patients who continued combination treatment and those who discontinued either NSAIDs or a conventional synthetic antirheumatic drug (csARD). The NSAID-sparing potential